EORTC elderly task force position paper: Approach to the older cancer patient

被引:236
作者
Pallis, A. G. [1 ]
Fortpied, C. [1 ]
Wedding, U. [2 ]
Van Nes, M. C. [3 ]
Penninckx, B.
Ring, A. [4 ]
Lacombe, D.
Monfardini, S. [5 ]
Scalliet, P. [6 ]
Wildiers, H. [7 ]
机构
[1] EORTC Headquarters, European Org Res & Treatment Canc, Dept Stat, B-1200 Brussels, Belgium
[2] Univ Jena, Dept Haematol Oncol & Palliat Care, D-07747 Jena, Germany
[3] CHR Citadelle, Dept Geriatr Med, B-4000 Liege, Belgium
[4] Royal Sussex Cty Hosp, Sussex Canc Ctr, Brighton BN2 5BE, E Sussex, England
[5] Inst Palazzolo, Geriatr Oncol Program, I-20149 Milan, Italy
[6] Catholic Univ Louvain, Clin Univ St Luc, Dept Radiotherapy, B-1200 Brussels, Belgium
[7] Univ Hosp Leuven, Dept Gen Med Oncol, Louvain, Belgium
关键词
EORTC; Elderly; Older; Aged; Geriatric oncology; Position paper; Clinical trials; Cancer in the older; COMPREHENSIVE GERIATRIC ASSESSMENT; CELL LUNG-CANCER; METASTATIC COLORECTAL-CANCER; HEMATOPOIETIC GROWTH-FACTORS; COLONY-STIMULATING FACTOR; INTERNATIONAL-SOCIETY; BREAST-CANCER; PHASE-III; ADJUVANT CHEMOTHERAPY; PROSTATE-CANCER;
D O I
10.1016/j.ejca.2010.02.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As a result of an increasing life expectancy, the incidence of cancer cases diagnosed in the older population is rising. Indeed, cancer incidence is 11-fold higher in persons over the age of 65 than in younger ones. Despite this high incidence of cancer in older patients, solid data regarding the most appropriate approach and best treatment for older cancer patients are still lacking, mostly due to under-representation of these patients in prospective clinical trials. The clinical behaviour of common malignant diseases, e.g. breast, ovarian and lung cancers, lymphomas and acute leukaemias, may be different in older patients because of intrinsic variation of the neoplastic cells and the ability of the tumour host to support neoplastic growth. The decision to treat or not these patients should be based on patients' functional age rather than the chronological age. Assessment of patients' functional age includes the evaluation of health, functional status, nutrition, cognition and the psychosocial and economic context. The purpose of this paper is to focus on the influence of age on cancer presentation and cancer management in older cancer patients and to provide suggestions on clinical trial development and methodology in this population. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1502 / 1513
页数:12
相关论文
共 112 条
[1]   SURVIVAL DETERMINANTS IN EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER - THE SOUTHWEST-ONCOLOGY-GROUP EXPERIENCE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1618-1626
[2]  
[Anonymous], NCCN CLIN PRACT GUID
[3]  
ANSARI R, 2007, P AM SOC CLIN ONCOL, V25
[4]   Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: Results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis - A Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study [J].
Ardizzoni, A ;
Favaretto, A ;
Boni, L ;
Baldini, E ;
Castiglioni, F ;
Antonelli, P ;
Pari, F ;
Tibaldi, C ;
Altieri, AM ;
Barbera, S ;
Cacciani, G ;
Raimondi, M ;
Tixi, L ;
Stefani, M ;
Monfardini, S ;
Antilli, A ;
Rosso, R ;
Paccagnella, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) :569-575
[5]   Telomeres and aging [J].
Aubert, Geraldine ;
Lansdorp, Peter M. .
PHYSIOLOGICAL REVIEWS, 2008, 88 (02) :557-579
[6]   Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help - A SIOG surgical task force prospective study [J].
Audisio, R. A. ;
Participants, P. A. C. E. ;
Pope, D. ;
Ramesh, H. S. J. ;
Gennari, R. ;
van Leeuwen, B. L. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 65 (02) :156-163
[7]  
Baker SD, 1997, CLIN GERIATR MED, V13, P169
[8]   Patients aged ≤ 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy [J].
Balducci, L ;
Lyman, GH .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1583-1584
[9]   Hematopoietic growth factors in the older cancer patient [J].
Balducci, L ;
Hardy, CL ;
Lyman, GH .
CURRENT OPINION IN HEMATOLOGY, 2001, 8 (03) :170-187
[10]   Geriatric oncology: challenges for the new century [J].
Balducci, L .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) :1741-1754